US 9090873
Development of dengue virus vaccine components
granted A61KA61K2039/5254A61P
Quick answer
US patent 9090873 (Development of dengue virus vaccine components) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/5254, A61P, A61P31/12, A61P31/14